Pseudomonas aeruginosa is a significant cause of nosocomial pneumonia and it is the most prevalent pathogen found in patients with severe injury or burns, where the associated mortality rate is up to 50%. Due to its poorly permeable outer membrane, P. aeruginosa shows strong resistance to a wide range of antibiotics. OprD is a specific porin for basic amino acids and apparently transports some carbapenems, a class of antibiotics with excellent activity against P. aeruginosa. However, there is little direct evidence for a specific bindingsite for carbapenems within the OprD channel. With the help of biased molecular dynamics simulations, we aim to understand the structure and function of OprD at the molecular level and thus to elucidate the interaction of drug molecules with this channel. Our study suggests that the movement of loop L2 is a major factor governing ion transport through OprD. It has also been found out that the dynamics of loops L3 and L7 in the constriction region of the porin play a vital role in antibiotic transport as well as in the modulation of ion transport through OprD. The orientation of the carbapenem molecule is important for translocation of the molecule and this is influenced by the electrostatic effect of the basic ladder (constituting of ARG 30 , ARG 39 ARG 391 & ARG 410 ) and negatively charged pocket (constituting of TYR 176 , TYR 282 & ASP 307 ) of OprD. Our study is not only helpful to understand the properties of OprD, but it also helps us to understand the properties of other members of the Outer membrane Carboxylic acid Channel (Occ) family. Representatives of this family, which show very high pairwise identity, are found in many pseudomonads and related bacteria.
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Theranyx, Marseille, France, 2 EPFL, Lausanne, Switzerland, 3 Uni. Basel, Basel, Switzerland, 4 CNRS, Grenoble, France, 5 AFMB, Marseille, France, 6 PSI, Villigen, Switzerland. Ion channels of the cys-loop receptor family are central to neurotransmission and first-class therapeutic targets, but structural information about pharmacologically relevant mammalian receptors is still fiercely missing. Here, we present an ongoing journey toward the structure determination of the 5-HT3 receptor. We tailored an easy-to-use and reproducible expression system: Inducible expression in human embryonic kidney cells cultured in suspension produced 6-8 mg of receptor per liter of culture. Affinity purification, enzymatic deglycosylation and limited proteolysis yielded pure, active, pentameric receptor solubilized in detergent. We developed a nanobody library and identified nanobodies that bind to the 5-HT3 receptor and modulate serotoninelicited currents at nanomolar concentrations. We are undertaking crystallization trials to try and obtain crystals of the 5-HT3 receptor diffracting X-rays to atomic resolution. is the active component of the Egyptian solitary digger wasp, Philanthus triangulum, venom which non-selectively inhibits several excitatory ion channels. To improve selectivity two synthetic analogues, Philanthotoxin-343 (PhTX-343) and Philanthotoxin-12 (PhTX-12), were developed. Previous work showed a 22-fold selectivity for PhTX-12 on embryonic muscle-type nicotinic acetylcholine receptors (M-nAChR) naturally expressed in the TE671 cell line in comparison to PhTX-343. In this study, we investigated the pharmacological action of both analogues on different mammalian hetero-oligomeric neuronal nicotinic acetylcholine receptor (N-nAChR) subunit combinations expressed in Xeno-pus oocytes. Whole-cell currents in response to application of acetylcholine alone or co-applied with PhTX-analogue were studied electrophysiologically using two-electrode voltage-clamp at three different membrane holding potentials (V H = À60 mV, À80 mV and À100 mV). Concentrationinhibition curves were constructed and IC 50 values estimated for each holding potential. The IC 50 values for PhTX-343 inhibition of a3b4, a3b2, a4b2 and a4b4 peak currents at À100 mV were 0.077 mM (n=9), 3.20 mM (n=8), 0.170 mM (n=7) and 0.28 mM (n=6) respectively; for PhTX-12 they were 2.03 mM (n=8), 36.0 mM (n=10), 0.430 mM (n=7) and 1.82 mM (n=9) respectively; i.e. in contrast to M-nAChR, PhTX-343 was more potent than PhTX-12 in all cases. The potency of PhTX-343 was strongly augmented by holding the cell at more negative V H while this was not the case for PhTX-12 where weak voltage-dependence was observed. The variation in potency is most likely due to a single amino acid change in the b2/4 subunit pore lining region. Therefore, we conclude that PhTX-343 works as a potent open channel blocker of the mammalian heteromeric N-nAChR and has binding site deep in the channel while the PhTX-12 site is near to the outside of channel.
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Studies on Fast Nach Receptor Kinetics Utilizing a New Approach to Ultra-Fast Compound Applications in Automated Patch Clamp Timm Danker 1 , Elke Guenther 2 . 1 NMI TT, Reutlingen, Germany, 2 NMI, Reutlingen, Germany. Ligand gated ion channels like nACh Receptors show fast inactivation kinetics in the ms range. Therefore, state of the art investigation of receptor kinetics and drug action requires the combination of patch clamp recording with advanced ultra-fast compound application systems like the piezodriven ''I-Tube''. So far, automated patch clamp systems have not been able to offer this combination. Here, we demonstrate automated ,,Q-Tube" recordings on nACh receptors using the Patchserver, a new device based on automated pipette micro positioning, gigaseal and whole cell formation. Unlike concurrent approaches utilizing ''planar'' chip designs, the method retains important features of the classical patch clamp methodology, including the possibility to optically select individual cells to be patched. This also enables the use of transiently transfected cells qualified by fluorescent markers. The system offered compound applications to the cell membrane with millisecond exchange-and exposure times, which is crucial to investigate the kinetics of fast inactivating ligand gated ion channels. Thus, the new method offers a cost efficient approach to significantly enhanced throughput and data quality for research on fast inactivating ligand gated ion channels.
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Asymmetric Agonist Selectivity of Agonist Sites in (a4b2)2a4 Nicotinic Acetylcholine Receptors: A Key Determinant of Agonist Efficacy Simone Mazzaferro, federica Gasparri, Karina New, Constanza Alcaino, Isabel Bermudez. Oxford Brookes University, OXFORD, United Kingdom. The a4b2 nicotinic acetylcholine receptor (nAChR) is the most abundant nAChR type in the brain, and converging evidence indicates that this type is a key mediator of the rewarding and reinforcing effects of nicotine. nAChR a4 and b2 subunits assemble in two alternate stoichiometries to produce (a4b2)2a4 and (a4b2)2b2 receptors that are activated by agonists with strikingly differing efficacies. Although the alternate receptors contain identical agonist sites at a4/b2 subunit interfaces, they possess isoformspecific subunit interfaces that are thought to underlie receptor stoichiometry functional signatures. Recent breakthroughs have identified an additional functionally relevant agonist binding site at the a4(þ)/a4(-) interface that is responsible for the signature sensitivity of (a4b2)2a4 nAChRs to activation by full and partial agonists, yet the structural basis for agonist efficacy at this receptor type is not yet understood. Applying the substituted cysteine accessibility method to individual agonist sites in concatenated (a4b2)2a4 receptors, we determined the agonist selectivity of the agonist sites of the (a4b2)2a4 receptor. We show that (a) the agonist site at the a4/a4 interface, but not the sites at a4/b2 interfaces, excludes large agonists; b) agonist effects on individual agonist sites differ depending on the interface location of the agonist sites. We conclude that agonist efficacy at (a4b2)2a4 receptors is first determined by the ability of agonists to bind all agonist sites and then by agonist-specific interactions with the agonist sites. The findings add another level of complexity to the structural mechanisms that govern partial agonism in hetero-pentameric ligand gated ion channels.
338a
Monday, February 17, 2014
